Where Should Leaders Really Start with AI in 2026?

Simon Crimp

SUBSCRIBE CONTACT US

Author



KEY TAKEAWAYS

  • AI adoption is now mainstream across Europe and the UK, but most large organisations remain stuck in pilots rather than delivering scaled, measurable impact on financial and risk metrics.


  • The real starting point for AI in 2026 is explicit board-level clarity on risk appetite, governance, and accountability – not another isolated proof of concept.


  • Sustainable AI value comes from treating it as a socio-technical system, with joined-up ownership across product, risk, operations, data, and HR rather than confining it to IT or innovation teams.


  • Organisations that define business outcomes first, assess data fitness and exposure rigorously, and run tightly scoped, measurable pilots are far more likely to move from experimentation to a repeatable AI production model.

4 MIN READ


Introduction

 

Business and technology leaders in larger organisations are starting 2026 with a familiar tension: AI is everywhere – pilots, proofs of concept, demos – but scaled, measurable value is still the exception rather than the rule.

 

Across Europe, AI adoption is now firmly mainstream. By 2025, around one in five EU enterprises with 10+ staff were using some form of AI, up from just 8% in 2023, with Nordic markets already above a third of firms using AI. In the UK, Office for National Statistics data shows that roughly a quarter of all businesses – and over 40% of larger firms with 250+ employees – report using AI tools, with a further wave planning adoption in the next few months.

 

Yet despite this momentum, most larger organisations are still stuck in pilots and localised experiments, not in fully scaled, governed capabilities. The question for boards and executive teams in 2026 is no longer "Should we use AI?" but "Where should we really start if we want impact we can see on the P&L, the balance sheet, and risk metrics?


Start by Deciding Your Risk Appetite

 

In bigger businesses – especially regulated or multi-country organisations – the question of when to move from pilots to scale is fundamentally a question of risk appetite.

 

Moving early brings higher uncertainty but also the chance to define the edge in your market: better customer experiences, faster cycle times, or radically different cost and risk profiles. Waiting allows you to borrow proven patterns – but risks leaving the field open to nimbler competitors or new entrants.

 

For boards, this is not a purely technical decision. It is a governance decision that should sit alongside capital allocation and major transformation commitments. That means getting clear on:

 

  • Which risk domains matter most (e.g. conduct, cyber, data protection, model risk, operational resilience)


  • Where you are prepared to experiment, and where you need stronger controls from day one


  • What "unacceptable" looks like – for customers, regulators, and your brand

 

Once this is explicit, your AI roadmap becomes a risk-shaped roadmap, not a list of disconnected experiments.


Treat AI as a Socio‑Technical System

 

In large, complex organisations, AI does not live in isolation. Models sit inside products, processes, supply chains, and front‑line workflows. Their behaviour is shaped as much by people, incentives and data governance as by algorithms.

 

That has two consequences for where you start:

 

  • You cannot fully outsource the risk. Even if you use third‑party models or platforms, regulators and customers will still hold you responsible for outcomes.


  • You need joined‑up ownership. AI initiatives that sit only in IT or innovation labs rarely get to scale. You need product, risk, operations, data and HR in the room from the outset.

 

Frameworks such as the NIST AI Risk Management Framework and emerging EU AI governance requirements are useful because they force you to think across the full lifecycle – from design and data sourcing through deployment, monitoring, and retirement – rather than treating AI as a one‑off technology decision.


Put Basic AI Governance in Place Before Chasing Use Cases

 

For larger organisations, the real starting line in 2026 is governance, not tools.

 

Before you launch another wave of pilots, ensure you have a robust and coherent governance framework in place. At minimum:

 

  • AI policy – what is allowed, what is prohibited, escalation routes, and who can approve higher‑risk experiments.


  • AI risk assessment template – ideally aligned to an established framework such as NIST AI RMF, so teams have a common language for impact, likelihood and controls.


  • A model and data register – a live inventory of AI systems, data sources, critical dependencies, and accountable owners.


  • Clear expectations for AI literacy and training – especially important for EU‑facing organisations, where regulatory expectations on competence and oversight are rising.

 

In practice, many larger organisations already have fragments of this in model risk, information security, and data protection. The opportunity in 2026 is to connect these into a visible, usable framework that lets business teams move faster because governance is clear, not in spite of it.


Define Value First – Then Choose the Technology

 

A recurring pattern in both UK and global surveys is that organisations struggle less with access to AI tools and more with identifying where those tools genuinely move the dial. In one recent UK study, difficulty finding meaningful use cases was cited more often than cost or skills as a barrier to adoption.

 

For larger organisations, the fastest way to dilute credibility is to start with a model or vendor and then go hunting for somewhere to point it. GenAI in particular can feel like a technology in search of a problem – part of the reason so many proofs of concept never cross into production.

 

Instead, reverse the logic:

 

  • Start from outcomes. Decide which outcomes matter most in the next 12–24 months – e.g. unit cost, time‑to‑serve, risk‑weighted assets, customer retention, regulatory capital, or resilience metrics.


  • Break outcomes into initiatives. Translate those outcomes into a shortlist of initiatives with clear measures of success.


  • Pick the right approach per initiative. For each, decide whether GenAI, classic analytics, automation, or process redesign is the right choice – or a hybrid – and what "good" looks like in plain business language.

 

Only then should you ask which AI tooling, platforms, or partners you need.


Get Serious About Data Fitness and Data Exposure

 

For any sizeable organisation, the gating question for AI is not "Do we have data?" but "Is our data good and safe enough to use at scale?"

 

A simple way to operationalise this is to use a Data Readiness & Safety scorecard before any new pilot or scaled deployment. Keep it high level, score each dimension 1–5, and agree thresholds for go, go with mitigations, or no‑go.

 

Two dimensions are usually enough to start:

 

  • Data fitness (is it good enough to deliver value?) – quality and accuracy, completeness, freshness, consistency, and whether you can trace and maintain the data over time.


  • Data exposure (is it safe enough to use?) – sensitivity (e.g. personal or commercially confidential data), rights and permissions, access controls, auditability, and the likely harm if the model is wrong or information leaks.

 

Treat access control, permissions, and auditability as gating items: if they are weak, you redesign or stop the pilot. This aligns with the direction of travel in UK and EU regulation, where boards are expected to evidence control over high‑impact AI systems, not simply innovation.


Design Your First Enterprise AI Pilots to Be Boring and Measurable

 

Once you have governance, value hypotheses, and data clarity, you are ready to run the kind of pilots that actually scale.

 

In larger organisations, the first wave of serious AI pilots should feel almost boring in scope: obvious value, obvious metrics, and tightly controlled risk. For example:

 

  • Reducing call‑handling or case‑handling time in a high‑volume service process


  • Accelerating document review or drafting in legal, compliance, or finance teams


  • Improving triage and routing for incidents, leads, or customer requests

 

For each pilot:

 

  • Define success in plain language. Time saved, error rates reduced, fewer hand‑offs, higher conversion, or NPS – and capture a baseline before you start.


  • Set up a small, accountable team. Blend product, operations, risk, and data/engineering; keep access and permissions tight.


  • Build human guardrails in from day one. Approvals, review steps, or escalation paths where impact is high – not bolted on after launch.


  • Make monitoring part of the design. Systems drift, user behaviour changes, and external data shifts.


  • Monitoring for performance, bias, and security should be routine, not a special project.

 

At the end of each pilot, make a single decision quickly: scale, iterate, or stop – and document the learning so the next use case starts from a stronger base.


From Scattergun Experiments to a Repeatable Production Line

 

By 2026, the differentiator between organisations that 'dabble' in AI and those that build a durable advantage is rarely the underlying model. It is whether AI is treated as a managed change programme with:

 

  • Disciplined delivery and portfolio management


  • Clear governance and risk ownership


  • Metrics that link directly to business outcomes, not just usage

 

For larger organisations, the most pragmatic path is to start small, but start deliberately:

 

  • Put basic AI governance and a data readiness lens in place.


  • Focus on a handful of use cases tied directly to strategic outcomes.


  • Run them through a repeatable production line: assess, pilot, test properly, scale only what works, and measure ROI against a clear baseline.

 

Done this way, AI stops being a patchwork of disconnected initiatives and becomes a feedback loop that consistently improves your time‑to‑value at enterprise scale.


AI Strategy Stress Test for Larger Organisations

 

If you’d like an external view on where to start, Cambridge Management Consulting runs a short AI Strategy Stress‑Test for larger and mid‑market organisations.

 

In a series of focused sessions, we look at your current AI experiments, data foundations and governance, then highlight use cases where AI can create real value with manageable risk – using the teams and platforms you already have. We also help you frame an achievable 6–12 month roadmap that balances ambition with control.

 

If you’d like to benchmark where you are today – and what a sensible next stage of AI adoption could look like for your organisation – we’d be happy to talk.

About the Author

About Us

Cambridge Management Consulting (Cambridge MC) is an international consulting firm that helps companies of all sizes have a better impact on the world. Founded in Cambridge, UK, initially to help the start-up community, Cambridge MC has grown to over 200 consultants working on projects in 25 countries. Our capabilities focus on supporting the private and public sector with their people, process and digital technology challenges.


What makes Cambridge Management Consulting unique is that it doesn’t employ consultants – only senior executives with real industry or government experience and the skills to advise their clients from a place of true credibility. Our team strives to have a highly positive impact on all the organisations they serve. We are confident there is no business or enterprise that we cannot help transform for the better.


Cambridge Management Consulting has offices or legal entities in Cambridge, London, New York, Paris, Dubai, Singapore and Helsinki, with further expansion planned in future. 

Contact Form

Contact - Craig Devolution Blog

Subscribe to our Newsletter

Blog Subscribe

SHARE CONTENT

Abstract technology image with the words 'Research Preview' overlaid.
by Charlotte Patrick • 17 November 2026
CAMBRIDGE AIQ | How can operators scale agentic AI towards autonomous networks? Our report sets out a five-stage roadmap, the key risks, and a framework for Stage 4 | READ PREVIEW & PURCHASE REPORT
16 November 2026
10 November 2026 – London – IThe search is on for the next generation of game-changing founders, pioneering companies and breakthrough innovations as #21toWatch opens the nominations window for its prestigious 2027 awards. Run by Cambridge Management Consulting, #21toWatch has a proven track record of spotlighting emerging talent and technologies from Cambridge and across the East of England - ventures with the potential to translate ambitious ideas into meaningful commercial and societal impact. Submissions typically span all areas of cutting-edge emerging innovation including artificial intelligence, deep tech, medtech, life sciences, biotechnology and climate technology. Some of the exciting entries already received for 2027 are as follows: In the ‘People’ category, biochemist, Dr Irina Gostimskaya, co-founder and CEO of Cambridge Molecular Computers, is a leading authority on reading, writing, and editing DNA. With her team at Cambridge Molecular Computers, she is building an alternative computing platform beyond silicon, using the programmability of DNA to solve previously intractable problems. Trading space for time, a DNA computer enables a desktop machine to outperform the world’s current fastest supercomputer, while consuming only a fraction of the energy. In the ‘Company’ category, pioneering femtech startup, Avline Health is building a pioneering intelligent clinical decision-support platform that combines individual patient risk assessment with evidence-informed treatment recommendations for genitourinary syndrome of menopause (GSM) after breast cancer. Combining vaginal microbiome sequencing, treatment history and longitudinal health data, Avline Health aims to provide clinicians with an objective severity score and a contraindication-aware treatment match, instead of a guess. CEO and co-founder, Dr. Josiane Chuisseu told us: “Vaginal microbiome testing does already exist - but nobody's built it for oncology before, and it’s very much needed. Up to 70% of breast cancer survivors develop genitourinary syndrome of menopause (GSM), a chronic and progressive condition caused by a drop in oestrogen levels - but it's chronically underdiagnosed because assessment still relies on subjective exams, and undertreated because clinicians are often too cautious to prescribe hormone therapy in cancer patients even when it's now shown to be safe. “As a result, two-thirds of women get the wrong diagnosis, and the treatments they do get are only effective less than 20% of the time." Meanwhile, in the ‘Things’ category, Metcycle is developing a scalable, energy-efficient technology to transform lithium-ion battery black mass into high-value critical materials. By addressing the industry’s key separation bottleneck, Metcycle aims to reduce reliance on energy-intensive and chemical-heavy recycling routes, enabling more economical recovery of battery metals while strengthening Europe’s domestic supply of critical raw materials. The 2027 #21toWatch campaign follows a year of incredible innovation across the region, with last year’s winning cohort continuing to make significant progress across investment, commercialisation and innovation: 2026 #21toWatch winner, Memorify has launched its Yoree memory platform following an oversubscribed £420k pre-seed investment round and a waitlist of more than 5,000 prospective users. Elsewhere, fellow winner, Loop52 has been selected for a share of a £2.7m Government-backed automotive innovation funding programme while another 2026 winner, Myonerv has won a £100k Innovate UK grant to advance clinical testing of its wearable stroke-rehabilitation technology, and 2026 winner, Cyclana Bio, which aims to find a cure for endometriosis, has secured approval for a 500-patient clinical study. Tim Passingham, founder and executive chairman of Cambridge Management Consulting, said: “Together, these achievements demonstrate the breadth of progress being made by the #21toWatch community, from attracting investment and bringing products to market to advancing clinical research and developing technologies with significant industrial potential. “#21toWatch is all about the importance of identifying promising innovators early and helping them gain the recognition and connections needed to scale. However, we are delighted that the impact of #21toWatch extends well beyond the awards.” Collectively, past winners have now raised more than £1billion, underlining the scale of the technical ambition among the ventures, and the importance of bringing such innovators to the attention of investors, customers and the wider business community. The #21toWatch shortlist – judged by a panel of independent judges - will be announced on 3 February 2027, with the final Top21, selected across three categories: People, Companies and Things, unveiled at an awards ceremony at Pembroke College, Cambridge, on 11 March 2027. Founders, companies and innovators can submit their own nominations through the #21toWatch website at https://www.21towatch.com/. Deadline for entries is 8 January 2027. Nominations are also invited from investors, universities and others across the innovation ecosystem. The judging process considers innovation, the challenge being addressed, influence, viability and memorability. Marks & Clerk returns as a premium sponsor of the 2027 #21toWatch campaign. Matthew Pinney, Office Managing Partner, Marks & Clerk Cambridge, said: “Cambridge has an extraordinary depth of entrepreneurial talent, and #21toWatch provides a valuable platform for recognising those innovators turning ambitious ideas into businesses with real commercial potential. We look forward to meeting this year’s cohort, learning more about their ambitions, and helping them protect and maximise the value of their innovations through intellectual property as they contribute to the region’s continuing success as a centre for innovation.” Further sponsors and the full judging panel will be announced shortly.
Big Ben and London cityscape at night – neon overlay
11 November 2026
Cambridge MC acquires Alpine Resourcing, a London-based public sector specialist, extending its reach across central and local government in the UK | READ PRESS RELEASE
A representation of agent boxes (prompts) linked into a workflow on a computer screen.
by Charlotte Patrick • 9 November 2026
RESEARCH & ANALYSIS | Cambridge AIQ assesses 13 vendors delivering agentic AI for service assurance, comparing four distinct strategies and the key factors operators must weigh | READ PREVIEW & PURCHASE REPORT
Audience at the recent launch event for the #21toWatch 2027 awards at the Glasshouse, Cambridge.
9 November 2026
A new monthly event series for scaleup founders, investors, and advisers at The Glasshouse, Cambridge. Starts 26 November with CMR Surgical’s Martin Frost CBE | READ FULL PRESS RELEASE
by Darren Sheppard • 5 November 2026
Procurement teams that invite structured external challenge — not resist it — build stronger, more defensible decisions. Learn how to use market testing and early supplier engagement to strengthen procurement authority, not undermine it | READ NOW
Visualisation of Earth with lines of data wrapped around it
by Eric Green • 4 November 2026
PROCUREMENT & AI | Neoscalers often buy the network last, under pressure. Eric Green explains the contract-term and cost risks, and how procurement discipline closes the gap | READ FULL ARTICLE NOW
30 October 2026
23 October 2026, Cambridge – Cambridge Management Consulting (Cambridge MC) has celebrated its annual corporate Green Day, bringing colleagues together for a day of environmental volunteering instead of a day in the office. On Friday 23 October, the international management consultancy, headquartered in Cambridge, teamed up with Cambridge City Council to improve wildlife habitat at Cherry Hinton Hall, a 12-hectare public park in south-east Cambridge. Working alongside the City Council’s Community Engagement team, the Cambridge MC team focused on the glade in the nature area at the rear of the park, cutting back grass, clearing away the cuttings, and sowing wildflower seeds. The work was designed to support the management of the green space and create better conditions for wildlife, while giving Cambridge MC colleagues a direct role in caring for their local environment. Tim Passingham, founder and executive chairman of Cambridge MC, explained: “Making a positive impact means being prepared to roll up our sleeves and contribute to the communities in which we work. Rather than treating environmental responsibility as an abstract corporate ambition, Green Day gives our colleagues the opportunity to contribute their time and effort to community green spaces – turning our commitment into something tangible by working alongside our local community, supporting the places we share and recognising that small, practical actions can make a difference when we take them together. “The initiative also reflects the importance of collaboration in environmental action. Individual volunteers, community groups, businesses, and local authorities all have an important role to play in maintaining accessible green spaces and supporting urban biodiversity.” While Cambridge was the focus of the company-wide initiative, Green Day extended beyond the city, with events taking place in the New Forest, and planned initiatives in London which were unfortunately cancelled due to adverse weather. In the New Forest, Cambridge MC colleagues worked with local environmental group ECO SWAY on preparing shared green spaces and planting pollinator-friendly bulbs to support bees and butterflies in the spring. Unfortunately, the London team’s efforts were cancelled due to Storm Austen, however they were excited to be joining local volunteers from Stoke Newington Urban Green (SNUG) to water and mulch young trees ahead of winter, helping them to establish and reach maturity. As an international consultancy, the team’s environmental efforts did not stop there. In France, one Managing Partner contributed to his local ecosystem by planting an oak tree, and in Portugal another Partner showed her support by planting several fruit trees. Elsewhere, consultants based outside of the UK or simply unable to travel to the three primary locations sowed tree bombs as a remote way of amplifying the day’s overall mission. Green Day forms part of Cambridge MC’s wider commitment to using its expertise, time, and resources to create positive impact. The purpose-beyond-profit company commits at least 10% of its profits to charitable causes that tally with its ‘Five Cs’: Children (and young people), Conservation (and sustainability), Cancer, Communications, and Cambridge (the Cambridge ecosystem). Alongside financial support, Cambridge MC also engages in purposeful pro bono work, gifting at least 1% of its time and expertise to help charities mature, digitalise, and reduce costs. And, uniquely, the company holds 1% of its equity in reserve for charitable use should an equity event occur. In September, Cambridge MC achieved Certified B Corporation status, marking a significant milestone in the company’s commitment to responsible business and recognising its approach to creating value for its team, clients, community, and the environment alongside commercial success. Tim said: “Our approach recognises that a responsible business is not defined solely by the advice it gives clients, but also by the contribution it makes to the communities and environments in which it operates. “By combining hands-on work with local partners across Cambridge and the New Forest, the Green Day initiative is bringing this principle to life – one green space at a time.”
A neon wireframe view of a city with roads and bridges.
by Paul Brooker • 15 October 2026
Sales Transformation | Manual workarounds and fragmented systems are costing telecom operators revenue and margin. Discover how to remove the Complexity Tax and unlock value | READ FULL ARTICLE NOW
More posts